Agilon Health, Inc. (NYSE:AGL) Stock Has Average Price Target of $102.25 According to Brokerages

Shares of Agilon Health, Inc. (NYSE:AGL) have been given a consensus recommendation of “Hold” by the fifteen ratings firms that are presently covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a sell recommendation, seven have given a hold recommendation and six have given a buy recommendation to the company. The average 12-month price target among brokerages that have covered the stock in the last year is $102.25.

AGL has been the topic of a number of research reports. Weiss Ratings reiterated a “sell (e+)” rating on shares of Agilon Health in a research report on Monday, August 24th. Barclays set a $111.00 target price on shares of Agilon Health and gave the company an “equal weight” rating in a research note on Thursday, August 6th. Robert W. Baird set a $116.00 target price on shares of Agilon Health in a research report on Thursday, August 6th. Royal Bank Of Canada set a $125.00 price target on shares of Agilon Health in a research note on Tuesday, September 15th. Finally, Truist Financial set a $112.00 price target on Agilon Health and gave the company a “hold” rating in a report on Thursday, August 6th.

Agilon Health Trading Up 3.2%

NYSE AGL opened at $85.03 on Tuesday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.08 and a current ratio of 1.08. Agilon Health has a one year low of $7.48 and a one year high of $133.04. The company has a 50-day simple moving average of $89.16 and a 200-day simple moving average of $79.91. The firm has a market capitalization of $1.43 billion, a PE ratio of -5.96 and a beta of 2.98.

Agilon Health (NYSE:AGL) last released its quarterly earnings data on Wednesday, August 5th. The company reported $1.04 earnings per share for the quarter, topping the consensus estimate of $0.14 by $0.90. Agilon Health had a negative net margin of 3.92% and a negative return on equity of 119.38%. The firm had revenue of $1.49 billion for the quarter, compared to analyst estimates of $1.45 billion. On average, equities analysts forecast that Agilon Health will post -2.90 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in AGL. State Street Corp bought a new position in shares of Agilon Health in the second quarter worth $30,024,000. The Manufacturers Life Insurance Company bought a new stake in shares of Agilon Health during the second quarter valued at about $355,000. Tidal Investments LLC bought a new stake in shares of Agilon Health during the second quarter valued at about $1,405,000. Engineers Gate Manager LP bought a new stake in shares of Agilon Health during the second quarter valued at about $516,000. Finally, Integrated Wealth Concepts LLC acquired a new stake in Agilon Health in the second quarter worth about $384,000.

Agilon Health Company Profile

Agilon Health, Inc is a healthcare company that helps primary care physicians transition from traditional fee-for-service medicine to value-based care. The company primarily works with independent physician practices that serve older adults, particularly Medicare Advantage members, with the goal of improving care coordination, patient outcomes and the overall healthcare experience.

Agilon provides a technology and services platform designed to support population health management. Its offerings include data analytics, clinical and administrative workflows, practice management support, care coordination resources and assistance with payer contracting.